Urinary and sexual manifestations of patients infected by HTLV-I
Autor(a) principal: | |
---|---|
Data de Publicação: | 2007 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFBA |
Texto Completo: | http://www.repositorio.ufba.br/ri/handle/ri/2899 |
Resumo: | p.191-196 |
id |
UFBA-2_8f22c7653232f33ea11303d71374e2c0 |
---|---|
oai_identifier_str |
oai:repositorio.ufba.br:ri/2899 |
network_acronym_str |
UFBA-2 |
network_name_str |
Repositório Institucional da UFBA |
repository_id_str |
1932 |
spelling |
Oliveira, PauloCastro, Néviton Matos deCarvalho Filho, Edgar Marcelino deOliveira, PauloCastro, Néviton Matos deCarvalho Filho, Edgar Marcelino de2011-09-27T16:39:16Z2011-09-27T16:39:16Z20071807-5932http://www.repositorio.ufba.br/ri/handle/ri/2899v.62, n.2p.191-196HTLV-I is considered to be a virus of low morbidity, since the principal diseases associated with this viral infection, HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T-cell leukemia/lymphoma (ATLL), are observed in less than 5% of infected individuals. Urinary symptoms are frequent in patients with myelopathy and consist principally of nocturia, frequency, urgency, and urinary incontinence; however, the importance of these dysfunctions and their correlation with myelopathy is still to be fully clarified. This review gives particular emphasis to the high frequency of urinary and sexual complaints not only in patients with myelopathy but also in individuals considered to be HTLV-I carriers. Detrusor overactivity and bladder-sphincter dyssynergia are the most common urodynamic findings. The fact that urinary complaints and urodynamic parameters reported in individuals considered to be carriers are similar to those detected in patients with myelopathy supports the hypothesis that urinary disorders may represent an oligosymptomatic form of HAM/TSP. Erectile dysfunction is frequently observed in HTLV-I-infected patients with or without myelopathy. Urinary tract infections are also highly prevalent in these patients. Despite the lack of an effective treatment for myelopathy, the use of anticholinergic drugs and phosphodiesterase type 5 (PDE5) inhibitors may improve urinary complaints and erectile dysfunction in these patients.Submitted by Rigaud Andréa (andrearigaud16@yahoo.com.br) on 2011-09-27T16:39:16Z No. of bitstreams: 1 v62n2a15.pdf: 66943 bytes, checksum: d2359389ed51ea5dd9c84d79d087332c (MD5)Made available in DSpace on 2011-09-27T16:39:16Z (GMT). No. of bitstreams: 1 v62n2a15.pdf: 66943 bytes, checksum: d2359389ed51ea5dd9c84d79d087332c (MD5) Previous issue date: 2007São PauloFaculdade de Medicina / USPHTLVErectile dysfunctionImpotenceUrinary infectionBladderUrodynamicsDisfunção eréctilImpotenciaInfecção urináriaBexigaUrodinâmicaUrinary and sexual manifestations of patients infected by HTLV-IClinicsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleengreponame:Repositório Institucional da UFBAinstname:Universidade Federal da Bahia (UFBA)instacron:UFBAinfo:eu-repo/semantics/openAccessORIGINALv62n2a15.pdfv62n2a15.pdfapplication/pdf66943https://repositorio.ufba.br/bitstream/ri/2899/1/v62n2a15.pdfd2359389ed51ea5dd9c84d79d087332cMD51LICENSElicense.txtlicense.txttext/plain1906https://repositorio.ufba.br/bitstream/ri/2899/2/license.txtd98afcfbbc71c31010e7a1be1485ebe4MD52TEXTv62n2a15.pdf.txtv62n2a15.pdf.txtExtracted texttext/plain27076https://repositorio.ufba.br/bitstream/ri/2899/3/v62n2a15.pdf.txtc1792c492b05528e0b7850ca24040208MD53ri/28992022-07-05 14:04:01.498oai:repositorio.ufba.br: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Repositório InstitucionalPUBhttp://192.188.11.11:8080/oai/requestopendoar:19322022-07-05T17:04:01Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)false |
dc.title.pt_BR.fl_str_mv |
Urinary and sexual manifestations of patients infected by HTLV-I |
dc.title.alternative.pt_BR.fl_str_mv |
Clinics |
title |
Urinary and sexual manifestations of patients infected by HTLV-I |
spellingShingle |
Urinary and sexual manifestations of patients infected by HTLV-I Oliveira, Paulo HTLV Erectile dysfunction Impotence Urinary infection Bladder Urodynamics Disfunção eréctil Impotencia Infecção urinária Bexiga Urodinâmica |
title_short |
Urinary and sexual manifestations of patients infected by HTLV-I |
title_full |
Urinary and sexual manifestations of patients infected by HTLV-I |
title_fullStr |
Urinary and sexual manifestations of patients infected by HTLV-I |
title_full_unstemmed |
Urinary and sexual manifestations of patients infected by HTLV-I |
title_sort |
Urinary and sexual manifestations of patients infected by HTLV-I |
author |
Oliveira, Paulo |
author_facet |
Oliveira, Paulo Castro, Néviton Matos de Carvalho Filho, Edgar Marcelino de |
author_role |
author |
author2 |
Castro, Néviton Matos de Carvalho Filho, Edgar Marcelino de |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Oliveira, Paulo Castro, Néviton Matos de Carvalho Filho, Edgar Marcelino de Oliveira, Paulo Castro, Néviton Matos de Carvalho Filho, Edgar Marcelino de |
dc.subject.por.fl_str_mv |
HTLV Erectile dysfunction Impotence Urinary infection Bladder Urodynamics Disfunção eréctil Impotencia Infecção urinária Bexiga Urodinâmica |
topic |
HTLV Erectile dysfunction Impotence Urinary infection Bladder Urodynamics Disfunção eréctil Impotencia Infecção urinária Bexiga Urodinâmica |
description |
p.191-196 |
publishDate |
2007 |
dc.date.issued.fl_str_mv |
2007 |
dc.date.accessioned.fl_str_mv |
2011-09-27T16:39:16Z |
dc.date.available.fl_str_mv |
2011-09-27T16:39:16Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://www.repositorio.ufba.br/ri/handle/ri/2899 |
dc.identifier.issn.none.fl_str_mv |
1807-5932 |
dc.identifier.number.pt_BR.fl_str_mv |
v.62, n.2 |
identifier_str_mv |
1807-5932 v.62, n.2 |
url |
http://www.repositorio.ufba.br/ri/handle/ri/2899 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Faculdade de Medicina / USP |
publisher.none.fl_str_mv |
Faculdade de Medicina / USP |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFBA instname:Universidade Federal da Bahia (UFBA) instacron:UFBA |
instname_str |
Universidade Federal da Bahia (UFBA) |
instacron_str |
UFBA |
institution |
UFBA |
reponame_str |
Repositório Institucional da UFBA |
collection |
Repositório Institucional da UFBA |
bitstream.url.fl_str_mv |
https://repositorio.ufba.br/bitstream/ri/2899/1/v62n2a15.pdf https://repositorio.ufba.br/bitstream/ri/2899/2/license.txt https://repositorio.ufba.br/bitstream/ri/2899/3/v62n2a15.pdf.txt |
bitstream.checksum.fl_str_mv |
d2359389ed51ea5dd9c84d79d087332c d98afcfbbc71c31010e7a1be1485ebe4 c1792c492b05528e0b7850ca24040208 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA) |
repository.mail.fl_str_mv |
|
_version_ |
1808459380514881536 |